(Q33879565)

29 July 2017

2 references

27 October 2020

25 January 2021

1 reference

Therapeutics of diabetes mellitus: focus on insulin analogues and insulin pumps (English)

1 reference

29 July 2017

1 reference

27 October 2020

1 reference

anti-diabetic medication

1 reference

27 October 2020

2 references

25 January 2021

Vasiliki Valla

1

1 reference

PubMed ID

20589066

29 July 2017

language of work or name

1 reference

26 May 2010

9 references

Experimental Diabetes Research

29 July 2017

14 March 2019

24 March 2019

25 June 2019

17 November 2019

20 November 2019

1 June 2020

27 October 2020

25 January 2021

9 references

29 July 2017

14 March 2019

24 March 2019

25 June 2019

17 November 2019

20 November 2019

1 June 2020

27 October 2020

25 January 2021

2010

1 reference

29 July 2017

178372

1 reference

Creative Commons Attribution 3.0 Unported

29 July 2017

8 references

14 March 2019

24 March 2019

25 June 2019

17 November 2019

20 November 2019

1 June 2020

27 October 2020

on focus list of Wikimedia project

25 January 2021

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Clinical practice in type 2 diabetes: After metformin and lifestyle, then what?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Further development of artificial pancreas: blocked by patents?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Beyond glycemic control: treating the entire type 2 diabetes disorder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Prevention of type 2 diabetes mellitus to reduce cardiovascular morbidity and mortality: a review of the evidence

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Insulin glulisine: a review of its use in the management of diabetes mellitus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

The value of self-monitoring of blood glucose: a review of recent evidence

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Treating type 2 diabetes: how safe are current therapeutic agents?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Initiating and intensifying insulin therapy for type 2 diabetes: why, when, and how.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Insulin analogues: an example of applied medical science

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

New modalities in the treatment of pregnancies complicated by diabetes: drugs and devices

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Consequences of delaying progression to optimal therapy in patients with type 2 diabetes not achieving glycemic goals

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Treatment of diabetes mellitus using an external insulin pump: the state of the art.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Insulin analogs: impact on treatment success, satisfaction, quality of life, and adherence

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Real-time glucose sensors in children and adolescents with type-1 diabetes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Past, present, and future of insulin pump therapy: better shot at diabetes control

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Demonstrating strategies for initiation of insulin therapy: matching the right insulin to the right patient

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Glucose control and use of continuous glucose monitoring in the intensive care unit: a critical review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Clinical use of real-time continuous glucose monitoring

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Use of continuous glucose monitoring in patients with type 1 diabetes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Continuous glucose monitoring time series and hypo/hyperglycemia prevention: requirements, methods, open problems

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Continuous glucose monitoring: physiological and technological challenges

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

The effects of pharmacologic agents for type 2 diabetes mellitus on body weight

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Bioartificial pancreas for the treatment of diabetes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Development of insulin delivery systems.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Insulin pump therapy (continuous subcutaneous insulin infusion).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Defining the role of insulin detemir in Basal insulin therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Intensive diabetes therapy and body weight: focus on insulin detemir

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Development and preclinical assessment of a bioartificial pancreas.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Insulin therapy in diabetes mellitus: how can the currently available injectable insulins be most prudently and efficaciously utilised?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Systematic literature review: quality of life associated with insulin pump use in Type 1 diabetes.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Insulin glulisine complementing basal insulins: a review of structure and activity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

The renaissance of insulin pump treatment in childhood type 1 diabetes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Continuous glucose monitoring and external insulin pump: towards a subcutaneous closed loop

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Feasibility of automating insulin delivery for the treatment of type 1 diabetes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

A review of human and analogue insulin trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

A new approach to diabetic control: fuzzy logic and insulin pump technology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Insulin pump therapy in type 1 diabetes mellitus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Hypoglycemia and ketoacidosis with insulin pump therapy in children and adolescents

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: A series of retrospective analyses of data from 1998 through 2002.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Continuous glucose monitoring and closed-loop systems

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

An overview on the development of a bio-artificial pancreas as a treatment of insulin-dependent diabetes mellitus.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Spotlight on insulin aspart in type 1 and 2 diabetes mellitus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Optimization of basal insulin delivery in Type 1 diabetes: a retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargine.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Insulin pump therapy: a meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877202

Individualism and insulin pump therapy

5 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

Quality of life and treatment satisfaction in patients being treated with long-acting insulin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

Long acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

Insulin pump therapy: guidelines for successful outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

Treatment of diabetes mellitus using an external insulin pump in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

Continuous subcutaneous insulin infusion versus multiple daily injections: modeling predicted benefits in relationship to baseline A1c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

Continuous subcutaneous insulin infusion leads to immediate, stable and long-term changes in metabolic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

Factors correlating with improved A1C in children using continuous subcutaneous insulin infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

Psychological aspects of continuous glucose monitoring in pediatric type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

The impact of continuous subcutaneous insulin infusion on health-related quality of life in children and adolescents with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

Cause of death in infants of women with pregestational diabetes mellitus and the relationship with glycemic control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

Relationships between glucose variability and conventional measures of glycemic control in continuously monitored patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

Insulin glargine and its role in glycaemic management of Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F178372

Insulin analogues: action profiles beyond glycaemic control

21 January 2018

1 reference

12 December 2020

Insulin glargine and cancer--an unsubstantiated allegation

1 reference

12 December 2020

The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes

1 reference

12 December 2020

Implementation of treatment protocols in the Diabetes Control and Complications Trial

1 reference

12 December 2020

[Pregnancy in type 1 diabetes: insulin pump versus intensified conventional therapy]

1 reference

12 December 2020

Transferring to insulin detemir from NPH insulin or insulin glargine in type 2 diabetes patients on basal-only therapy with oral antidiabetic drugs improves glycaemic control and reduces weight gain and risk of hypoglycaemia: 14-week follow-up data

1 reference

12 December 2020

Gestational diabetes mellitus

1 reference

12 December 2020

Identifiers

DOI

10.1155/2010/178372

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

PubMed ID

20589066